STEPHANIE SCHAFER: Open Payments
NPI 1093202731 · CAVE CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,306 in 122 payments from 19 companies in 2025. Trend: 2023 $360 · 2024 $1,622 · 2025 $2,306
Food & beverage: $2,211Education: $95
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $423 |
| Regeneron Healthcare Solutions, Inc. | 11 | $304 |
| ABBVIE INC. | 13 | $264 |
| Galderma Laboratories, L.P. | 25 | $216 |
| Janssen Biotech, Inc. | 9 | $206 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $129 |
| Organon LLC | 11 | $114 |
| GENZYME CORPORATION | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Genentech USA, Inc. | 3 | $89 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, Xolair, ILUMYA, VTAMA.
Industry payments across AZ — which companies pay providers there.
